Unmet challenges of structural genomics

Current Opinion in Structural Biology

Volumn 20, Issue 5, 2010, Pages 587-597

  Chruszcz, Maksymilian ^a,b,c   Domagalski, Marcin ^a,b,c   Osinski, Tomasz ^a,b,c   Wlodawer, Alexander ^d   Minor, Wladek ^a,b,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Center for Structural Genomics of Infectious Diseases   (United States)

^c Midwest Center for Structural Genomics   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; AUTOMATION; CRYSTALLIZATION; CRYSTALLOGRAPHY; DATA ANALYSIS; HUMAN; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DATABASE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; QUALITY CONTROL; REVIEW; STRUCTURAL GENOMICS; STRUCTURAL HOMOLOGY; STRUCTURE ANALYSIS; X RAY DIFFRACTION;

ANIMALS; CRYSTALLIZATION; DRUG DISCOVERY; GENOMICS; HUMANS; MODELS, MOLECULAR; PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 78049419038     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sbi.2010.08.001     Document Type: Review

References (80)

1. Jaroszewski L., Li Z., Krishna S.S., Bakolitsa C., Wooley J., Deacon A.M., Wilson I.A., Godzik A. Exploration of uncharted regions of the protein universe. PLoS Biol 2009, 7:e1000205.
2. Dessailly B.H., Nair R., Jaroszewski L., Fajardo J.E., Kouranov A., Lee D., Fiser A., Godzik A., Rost B., Orengo C. PSI-2: structural genomics to cover protein domain family space. Structure 2009, 17:869-881.
3. Fan E., Baker D., Fields S., Gelb M.H., Buckner F.S., Van Voorhis W.C., Phizicky E., Dumont M., Mehlin C., Grayhack E., et al. Structural genomics of pathogenic protozoa: an overview. Methods Mol Biol 2008, 426:497-513.
4. Ioerger T.R., Sacchettini J.C. Structural genomics approach to drug discovery for Mycobacterium tuberculosis. Curr Opin Microbiol 2009, 12:318-325.
5. Edwards A. Large-scale structural biology of the human proteome. Annu Rev Biochem 2009, 78:541-568.
6. Anderson W.F. Structural genomics and drug discovery for infectious diseases. Infect Disord Drug Targets 2009, 9:507-517.
7. Myler P.J., Stacy R., Stewart L., Staker B.L., Van Voorhis W.C., Varani G., Buchko G.W. The Seattle Structural Genomics Center for Infectious Disease (SSGCID). Infect Disord Drug Targets 2009, 9:493-506.
8. Albeck S., Alzari P., Andreini C., Banci L., Berry I.M., Bertini I., Cambillau C., Canard B., Carter L., Cohen S.X., et al. SPINE bioinformatics and data-management aspects of high-throughput structural biology. Acta Crystallogr D Biol Crystallogr 2006, 62:1184-1195.
9. Joachimiak A. High-throughput crystallography for structural genomics. Curr Opin Struct Biol 2009, 19:573-584.
10. Makino S., Goren M.A., Fox B.G., Markley J.L. Cell-free protein synthesis technology in NMR high-throughput structure determination. Methods Mol Biol 2010, 607:127-147.
11. Tyler R.C., Aceti D.J., Bingman C.A., Cornilescu C.C., Fox B.G., Frederick R.O., Jeon W.B., Lee M.S., Newman C.S., Peterson F.C., et al. Comparison of cell-based and cell-free protocols for producing target proteins from the Arabidopsis thaliana genome for structural studies. Proteins 2005, 59:633-643.
12. Torizawa T., Shimizu M., Taoka M., Miyano H., Kainosho M. Efficient production of isotopically labeled proteins by cell-free synthesis: a practical protocol. J Biomol NMR 2004, 30:311-325.
13. Payne D.J., Gwynn M.N., Holmes D.J., Rosenberg M. Genomic approaches to antibacterial discovery. Methods Mol Biol 2004, 266:231-259.
14. Derewenda Z.S., Vekilov P.G. Entropy and surface engineering in protein crystallization. Acta Crystallogr D Biol Crystallogr 2006, 62:116-124.
15. Kim Y., Quartey P., Li H., Volkart L., Hatzos C., Chang C., Nocek B., Cuff M., Osipiuk J., Tan K., et al. Large-scale evaluation of protein reductive methylation for improving protein crystallization. Nat Methods 2008, 5:853-854.
16. Dong A., Xu X., Edwards A.M., Chang C., Chruszcz M., Cuff M., Cymborowski M., Di Leo R., Egorova O., Evdokimova E., et al. In situ proteolysis for protein crystallization and structure determination. Nat Methods 2007, 4:1019-1021.
17. Wernimont A., Edwards A. In situ proteolysis to generate crystals for structure determination: an update. PLoS One 2009, 4:e5094.
18. Gerdts C.J., Elliott M., Lovell S., Mixon M.B., Napuli A.J., Staker B.L., Nollert P., Stewart L. The plug-based nanovolume Microcapillary Protein Crystallization System (MPCS). Acta Crystallogr D Biol Crystallogr 2008, 64:1116-1122.
19. Hazes B., Price L. A nanovolume crystallization robot that creates its crystallization screens on-the-fly. Acta Crystallogr D Biol Crystallogr 2005, 61:1165-1171.
20. Li L., Mustafi D., Fu Q., Tereshko V., Chen D.L., Tice J.D., Ismagilov R.F. Nanoliter microfluidic hybrid method for simultaneous screening and optimization validated with crystallization of membrane proteins. Proc Natl Acad Sci U S A 2006, 103:19243-19248.
21. Zheng B., Gerdts C.J., Ismagilov R.F. Using nanoliter plugs in microfluidics to facilitate and understand protein crystallization. Curr Opin Struct Biol 2005, 15:548-555.
22. Koclega K.D., Chruszcz M., Zimmerman M.D., Bujacz G., Minor W. 'Hot' macromolecular crystals. Cryst Growth Des 2009, 10:580.
23. Zhang Y., Thiele I., Weekes D., Li Z., Jaroszewski L., Ginalski K., Deacon A.M., Wooley J., Lesley S.A., Wilson I.A., et al. Three-dimensional structural view of the central metabolic network of Thermotoga maritima. Science 2009, 325:1544-1549.
24. Page R., Grzechnik S.K., Canaves J.M., Spraggon G., Kreusch A., Kuhn P., Stevens R.C., Lesley S.A. Shotgun crystallization strategy for structural genomics: an optimized two-tiered crystallization screen against the Thermotoga maritima proteome. Acta Crystallogr D Biol Crystallogr 2003, 59:1028-1037.
25. Farr R.G., Perryman A.L., Samudzi C.T. Re-clustering the database for crystallization of macromolecules. J Cryst Growth 1998, 183:653-668.
26. Hennessy D., Buchanan B., Subramanian D., Wilkosz P.A., Rosenberg J.M. Statistical methods for the objective design of screening procedures for macromolecular crystallization. Acta Crystallogr D Biol Crystallogr 2000, 56:817-827.
27. Koide S. Engineering of recombinant crystallization chaperones. Curr Opin Struct Biol 2009, 19:449-457.
28. Kossiakoff A.A., Koide S. Understanding mechanisms governing protein-protein interactions from synthetic binding interfaces. Curr Opin Struct Biol 2008, 18:499-506.
29. Price W.N., Chen Y., Handelman S.K., Neely H., Manor P., Karlin R., Nair R., Liu J., Baran M., Everett J., et al. Understanding the physical properties that control protein crystallization by analysis of large-scale experimental data. Nat Biotechnol 2009, 27:51-57.
30. Slabinski L., Jaroszewski L., Rychlewski L., Wilson I.A., Lesley S.A., Godzik A. XtalPred: a web server for prediction of protein crystallizability. Bioinformatics 2007, 23:3403-3405.
31. Graslund S., Nordlund P., Weigelt J., Hallberg B.M., Bray J., Gileadi O., Knapp S., Oppermann U., Arrowsmith C., Hui R., et al. Protein production and purification. Nat Methods 2008, 5:135-146.
32. Bhattacharya A., Tejero R., Montelione G.T. Evaluating protein structures determined by structural genomics consortia. Proteins 2007, 66:778-795.
33. Chruszcz M, Borek D, Domagalski M, Otwinowski Z, Minor W: X-ray diffraction experiment-the last experiment in the structure elucidation process. In Structural Genomics, Part C. Edited by: Elsevier Academic Press Inc; 2009:23-40. [Advances in Protein Chemistry and Structural Biology, vol 77].
34. Grabowski M., Chruszcz M., Zimmerman M.D., Kirillova O., Minor W. Benefits of structural genomics for drug discovery research. Infect Disord Drug Targets 2009, 9:459-474.
35. Chen V.B., Arendall W.B., Headd J.J., Keedy D.A., Immormino R.M., Kapral G.J., Murray L.W., Richardson J.S., Richardson D.C. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 2010, 66:12-21.
36. Borek D., Cymborowski M., Machius M., Minor W., Otwinowski Z. Diffraction data analysis in the presence of radiation damage. Acta Crystallogr D Biol Crystallogr 2010, 66:426-436.
37. Joosten R.P., Vriend G. PDB improvement starts with data deposition. Science 2007, 317:195-196.
38. Joosten R.P., Womack T., Vriend G., Bricogne G. Re-refinement from deposited X-ray data can deliver improved models for most PDB entries. Acta Crystallogr D Biol Crystallogr 2009, 65:176-185.
39. Wlodawer A., Minor W., Dauter Z., Jaskolski M. Protein crystallography for non-crystallographers, or how to get the best (but not more) from published macromolecular structures. FEBS J 2008, 275:1-21.
40. Joosten R.P., Salzemann J., Bloch V., Stockinger H., Berglund A.C., Blanchet C., Bongcam-Rudloff E., Combet C., Da Costa A.L., Deleage G., et al. PDB_REDO: automated re-refinement of X-ray structure models in the PDB. J Appl Crystallogr 2009, 42:376-384.
41. Kaufmann K.W., Lemmon G.H., Deluca S.L., Sheehan J.H., Meiler J. Practically useful: what the Rosetta protein modeling suite can do for you. Biochemistry 2010, 49:2987-2998.
42. Moult J. Comparative modeling in structural genomics. Structure 2008, 16:14-16.
43. Liu J., Montelione G.T., Rost B. Novel leverage of structural genomics. Nat Biotechnol 2007, 25:849-851.
44. Kanou K., Hirata T., Iwadate M., Terashi G., Umeyama H., Takeda-Shitaka M. HUMAN FAMSD-BASE: high quality protein structure model database for the human genome using the FAMSD homology modeling method. Chem Pharm Bull (Tokyo) 2010, 58:66-75.
45. Yura K., Yamaguchi A., Go M. Coverage of whole proteome by structural genomics observed through protein homology modeling database. J Struct Funct Genomics 2006, 7:65-76.
46. Critical assessment of methods of protein structure prediction-Round VIII. Proteins 2009, 77(Suppl 9):1-228.
47. Tress M.L., Ezkurdia I., Richardson J.S. Target domain definition and classification in CASP8. Proteins 2009, 77(Suppl 9):10-17.
48. Hura G.L., Menon A.L., Hammel M., Rambo R.P., Poole F.L., Tsutakawa S.E., Jenney F.E., Classen S., Frankel K.A., Hopkins R.C., et al. Robust, high-throughput solution structural analyses by small angle X-ray scattering (SAXS). Nat Methods 2009, 6:606-612.
49. Konrat R. The protein meta-structure: a novel concept for chemical and molecular biology. Cell Mol Life Sci 2009, 66:3625-3639.
50. Binkowski T.A., Joachimiak A. Protein functional surfaces: global shape matching and local spatial alignments of ligand binding sites. BMC Struct Biol 2008, 8:45.
51. Ascone I., Strange R. Biological X-ray absorption spectroscopy and metalloproteomics. J Synchrotron Radiat 2009, 16:413-421.
52. Zheng H., Chruszcz M., Lasota P., Lebioda L., Minor W. Data mining of metal ion environments present in protein structures. J Inorg Biochem 2008, 102:1765-1776.
53. Payne D.J., Gwynn M.N., Holmes D.J., Pompliano D.L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 2007, 6:29-40.
54. Shah S., Federoff H.J. Drug discovery dilemma and Cura quartet collaboration. Drug Discov Today 2009, 14:1006-1010.
55. Arcus V.L., Lott J.S., Johnston J.M., Baker E.N. The potential impact of structural genomics on tuberculosis drug discovery. Drug Discov Today 2006, 11:28-34.
56. Weigelt J., McBroom-Cerajewski L.D., Schapira M., Zhao Y., Arrowsmith C.H. Structural genomics and drug discovery: all in the family. Curr Opin Chem Biol 2008, 12:32-39.
57. Artz J.D., Dunford J.E., Arrowood M.J., Dong A., Chruszcz M., Kavanagh K.L., Minor W., Russell R.G., Ebetino F.H., Oppermann U., et al. Targeting a uniquely nonspecific prenyl synthase with bisphosphonates to combat cryptosporidiosis. Chem Biol 2008, 15:1296-1306.
58. Weigelt J. Structural genomics-impact on biomedicine and drug discovery. Exp Cell Res 2010, 316:1332-1338.
59. Edwards A.M., Bountra C., Kerr D.J., Willson T.M. Open access chemical and clinical probes to support drug discovery. Nat Chem Biol 2009, 5:436-440.
60. Van Voorhis W.C., Hol W.G., Myler P.J., Stewart L.J. The role of medical structural genomics in discovering new drugs for infectious diseases. PLoS Comput Biol 2009, 5:e1000530.
61. Cavasotto C.N., Phatak S.S. Homology modeling in drug discovery: current trends and applications. Drug Discov Today 2009, 14:676-683.
62. Kalyanaraman C., Imker H.J., Fedorov A.A., Fedorov E.V., Glasner M.E., Babbitt P.C., Almo S.C., Gerlt J.A., Jacobson M.P. Discovery of a dipeptide epimerase enzymatic function guided by homology modeling and virtual screening. Structure 2008, 16:1668-1677.
63. Song L., Kalyanaraman C., Fedorov A.A., Fedorov E.V., Glasner M.E., Brown S., Imker H.J., Babbitt P.C., Almo S.C., Jacobson M.P., et al. Prediction and assignment of function for a divergent N-succinyl amino acid racemase. Nat Chem Biol 2007, 3:486-491.
64. Antonyuk S., Strange R.W., Hasnain S.S. Structural discovery of small molecule binding sites in Cu-Zn human superoxide dismutase familial amyotrophic lateral sclerosis mutants provides insights for lead optimization. J Med Chem 2010, 53:1402-1406.
65. Nowak R.J., Cuny G.D., Choi S., Lansbury P.T., Ray S.S. Improving binding specificity of pharmacological chaperones that target mutant superoxide dismutase-1 linked to familial amyotrophic lateral sclerosis using computational methods. J Med Chem 2010, 53:2709-2718.
66. Gaudet P., Lane L., Fey P., Bridge A., Poux S., Auchincloss A., Axelsen K., Braconi Quintaje S., Boutet E., Brown P. Collaborative annotation of genes and proteins between UniProtKB/Swiss-Prot and dictyBase. Database (Oxford) 2009, 2009:bap016.
67. Hodis E., Prilusky J., Martz E., Silman I., Moult J., Sussman J.L. Proteopedia-a scientific 'wiki' bridging the rift between three-dimensional structure and function of biomacromolecules. Genome Biol 2008, 9:R121.
68. Raush E., Totrov M., Marsden B.D., Abagyan R. A new method for publishing three-dimensional content. PLoS One 2009, 4:e7394.
69. Schnoes A.M., Brown S.D., Dodevski I., Babbitt P.C. Annotation error in public databases: misannotation of molecular function in enzyme superfamilies. PLoS Comput Biol 2009, 5:e1000605.
70. Laskowski R.A., Watson J.D., Thornton J.M. ProFunc: a server for predicting protein function from 3D structure. Nucleic Acids Res 2005, 33:W89-W93.
71. Gherardini P.F., Helmer-Citterich M. Structure-based function prediction: approaches and applications. Brief Funct Genomic Proteomic 2008, 7:291-302.
72. Proudfoot M., Kuznetsova E., Sanders S.A., Gonzalez C.F., Brown G., Edwards A.M., Arrowsmith C.H., Yakunin A.F. High throughput screening of purified proteins for enzymatic activity. Methods Mol Biol 2008, 426:331-341.
73. Baran R., Reindl W., Northen T.R. Mass spectrometry based metabolomics and enzymatic assays for functional genomics. Curr Opin Microbiol 2009, 12:547-552.
74. Nettleship J.E., Brown J., Groves M.R., Geerlof A. Methods for protein characterization by mass spectrometry, thermal shift (ThermoFluor) assay, and multiangle or static light scattering. Methods Mol Biol 2008, 426:299-318.
75. Berman H.M., Westbrook J.D., Gabanyi M.J., Tao W., Shah R., Kouranov A., Schwede T., Arnold K., Kiefer F., Bordoli L., et al. The protein structure initiative structural genomics knowledgebase. Nucleic Acids Res 2009, 37:D365-368.
76. Nam K.H., Sung M.W., Hwang K.Y. Structural insights into the substrate recognition properties of beta-glucosidase. Biochem Biophys Res Commun 2010, 391:1131-1135.
77. Fan H., Irwin J.J., Webb B.M., Klebe G., Shoichet B.K., Sali A. Molecular docking screens using comparative models of proteins. J Chem Inf Model 2009, 49:2512-2527.
78. Movshovitz-Attias D., London N., Schueler-Furman O. On the use of structural templates for high-resolution docking. Proteins 2010, 78:1939-1949.
79. Kundrotas P.J., Vakser I.A. Accuracy of protein-protein binding sites in high-throughput template-based modeling. PLoS Comput Biol 2010, 6:e1000727.
80. Emsley P., Lohkamp B., Scott W.G., Cowtan K. Features and development of Coot. Acta Crystallogr D Biol Crystallogr 2010, 66:486-501.